灌流システムの市場規模、シェア、成長分析：年齢層別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

灌流システムの世界市場規模は、2023年に12億9,000万米ドルと評価され、2024年の13億4,000万米ドルから2032年には18億2,000万米ドルに成長し、予測期間（2025～2032年）のCAGRは3.9％で成長する見通しです。

灌流システム市場は、特に臓器移植や細胞研究などの医療・生物医学研究において極めて重要です。これらの特殊な装置は、体外の生体組織や臓器に酸素や栄養を含んだ液体を制御された状態で供給することを可能にし、輸送や実験のために臓器の生存能力を維持します。灌流システムはドナーの臓器保存と移植成功率を高めるため、世界の臓器不足の中で臓器移植の需要が高まっていることが市場の成長を牽引しています。常温灌流のような技術革新は、臓器の維持時間を延長し、生存率評価を向上させます。さらに、製薬やバイオテクノロジーの研究においては、灌流システムは細胞や組織の培養を促進し、疾病研究や治療開発のための生理学的条件をシミュレートします。これらの技術への投資は、臨床結果と研究能力を向上させ、市場の成長を促進すると予想されます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

灌流システム市場規模：年齢層別

• 市場概要
• 大人
• 小児

灌流システム市場規模：用途別

• 市場概要
• 心肺灌流システム
  • 酸素供給装置
  • 人工心肺
  • 灌流ポンプ
  • カニューレ
  • 監視システム
  • その他
  • 動脈フィルター
  • 貯水池
  • データ管理システム
  • 心停止剤送達システム
  • 熱交換器
  • アクセサリー
• セル灌流システム
  • バイオリアクター灌流システム
  • マイクロ流体灌流システム
  • 重力/圧力駆動灌流システム
  • 哺乳類の小さな器官灌流システム
• 生体外臓器灌流システム
  • 低体温
  • 常温
• 体外式膜型人工肺（ECMO）
• 隔離臓器灌流システム

灌流システム市場規模：エンドユーザー別

• 市場概要
• 病院とASC
• 専門クリニック
• その他

灌流システム市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• ICU Medical（United States）
• B. Braun（Germany）
• Delcath Systems（United States）
• Fresenius Medical Care（Germany）
• Terumo Corporation（Japan）
• Medtronic（Ireland）
• Getinge AB（Sweden）
• LivaNova（United Kingdom）
• Edwards Lifesciences（United States）
• Nipro Corporation（Japan）
• CytoSorbents Corporation（United States）
• Spectrum Medical（United Kingdom）
• Eurosets（Italy）
• Biomedica（Austria）
• Soma Technology（United States）

結論と提言

Global Perfusion System Market size was valued at USD 1.29 billion in 2023 and is poised to grow from USD 1.34 billion in 2024 to USD 1.82 billion by 2032, growing at a CAGR of 3.9% during the forecast period (2025-2032).

The perfusion system market is crucial in medical and biomedical research, particularly for organ transplantation and cellular studies. These specialized devices enable controlled delivery of oxygenated and nutrient-dense fluids to biological tissues or organs outside the body, preserving organ viability for transport and experimentation. The market's growth is driven by the rising demand for organ transplants amidst a global organ shortage, as perfusion systems enhance donor organ preservation and transplant success rates. Innovations like normothermic perfusion extend organ maintenance time and improve viability assessment. Additionally, in pharmaceutical and biotechnology research, perfusion systems facilitate cell and tissue culture, simulating physiological conditions for disease study and treatment development. Investment in these technologies is expected to propel market growth, enhancing clinical outcomes and research capabilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Perfusion System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Perfusion System Market Segments Analysis

Global Perfusion System Market is segmented by Age Group, Application, End User and region. Based on Age Group, the market is segmented into Adults and Pediatrics. Based on Application, the market is segmented into Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System, Extracorporeal Membrane Oxygenation (ECMO) and Isolated Organ Perfusion Systems. Based on End User, the market is segmented into Hospitals & ASCs, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Perfusion System Market

The rising incidence of organ failure and the heightened demand for transplantable organs significantly propel the global perfusion system market. These innovative systems are vital for preserving and evaluating donor organs, ultimately enhancing the success rates of transplantation procedures. As the need for effective organ preservation techniques escalates, perfusion systems become increasingly crucial in ensuring that donor organs remain viable for transplantation. This growing reliance on advanced perfusion technology underscores its importance in the healthcare landscape, as it not only addresses the challenges associated with organ availability but also aims to improve patient outcomes in transplantation.

Restraints in the Global Perfusion System Market

The Global Perfusion System market faces significant obstacles due to rigorous regulatory demands and the necessity for adherence to high safety and quality standards. These stringent requirements can delay the innovation, development, and approval processes for new perfusion technologies, hindering the timely introduction of advanced solutions into the market. As companies strive to meet these complex regulations, the pace of technological advancements may be impeded, ultimately affecting their ability to commercialize enhanced perfusion systems. This complex landscape presents challenges that can slow down growth and limit opportunities within the industry, impacting overall market dynamics.

Market Trends of the Global Perfusion System Market

The Global Perfusion System market is witnessing a significant trend towards normothermic perfusion, which is rapidly gaining traction among healthcare professionals and transplant centers. This innovative approach maintains donor organs at physiological temperatures during transportation, enhancing their viability and extending preservation times. As a result, it facilitates thorough evaluation of organ function prior to transplantation, thereby increasing the likelihood of successful grafting and improving patient outcomes. The growing emphasis on optimizing organ preservation techniques and the rising demand for transplantable organs are driving investment and research into normothermic perfusion systems, making them a key focus area in the evolving landscape of the perfusion market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Perfusion System Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Adults
• Pediatrics

Global Perfusion System Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cardiopulmonary Perfusion System
  • Oxygenators
  • Heart-Lung Machine
  • Perfusion Pumps
  • Cannula
  • Monitoring System
  • Others
  • Arterial Filters
  • Reservoirs
  • Data Management Systems
  • Cardioplegia Delivery Systems
  • Heat Exchangers
  • Accessories
• Cell Perfusion System
  • Bioreactor Perfusion System
  • Microfluidic Perfusion System
  • Gravity/Pressure-driven Perfusion System
  • Small Mammal Organ Perfusion System
• Ex-Vivo Organ Perfusion System
  • Hypothermic
  • Normothermic
• Extracorporeal Membrane Oxygenation (ECMO)
• Isolated Organ Perfusion Systems

Global Perfusion System Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & ASCs
• Specialty Clinics
• Others

Global Perfusion System Market Size & CAGR (2025-2032)

• North America (Age Group, Application, End User)
  • US
  • Canada
• Europe (Age Group, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Age Group, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Age Group, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Age Group, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• ICU Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Delcath Systems (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CytoSorbents Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spectrum Medical (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurosets (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomedica (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soma Technology (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations